<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04142827</url>
  </required_header>
  <id_info>
    <org_study_id>High Flow in Bronchiectasis</org_study_id>
    <nct_id>NCT04142827</nct_id>
  </id_info>
  <brief_title>The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)</brief_title>
  <acronym>BX</acronym>
  <official_title>The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Giuseppe Fiorentino</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Monaldi Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is intended to understand the benefit of Long Term Home care Therapy with nasal
      High flow in Bronchiectasis patients at home. Primary end point is to evaluate daily life
      compared to usual care and secondary is to evaluate the changes in lung function
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 4, 2019</start_date>
  <completion_date type="Anticipated">September 3, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 3, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improvment Daily Life</measure>
    <time_frame>1 year</time_frame>
    <description>measurement via questionary SGRQ</description>
  </primary_outcome>
  <primary_outcome>
    <measure>measurement of Sputum production</measure>
    <time_frame>1 year</time_frame>
    <description>Microbiological Mesurement of sputum</description>
  </primary_outcome>
  <primary_outcome>
    <measure>measurement Exercise tolerance</measure>
    <time_frame>1 year</time_frame>
    <description>measurement with 6 minutes walking test</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of missed working or school day</measure>
    <time_frame>1 year</time_frame>
    <description>Calculation of days of sick</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time from first exacerbations</measure>
    <time_frame>1 year</time_frame>
    <description>measurement of time dalay from last exacerbation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>number of exacerbations including their durations and severity</measure>
    <time_frame>1 year</time_frame>
    <description>counting form their clinic diary of number of exacerbation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Arterial Blood Glass</measure>
    <time_frame>1 year</time_frame>
    <description>Arterial Blood Glass draw at time zero and time 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unit of Nitric Oxide</measure>
    <time_frame>1 year</time_frame>
    <description>Measurement with Nitric oxide device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of Reactive C-Protein</measure>
    <time_frame>1 year</time_frame>
    <description>comparation of blood draw</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Bronchiectasis Adult</condition>
  <condition>Lung Infection</condition>
  <condition>Quality of Life</condition>
  <condition>Humidifier Lung</condition>
  <condition>COPD Exacerbation</condition>
  <condition>COPD Asthma</condition>
  <arm_group>
    <arm_group_label>Therapy with high flow humidification</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will be activated after enrollment with myAirvo2 device at home for 6 months before first observations</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Therapy with usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The patients will be under usual care for observational</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>High Flow Humidification</intervention_name>
    <description>myAirvo2 gives at home for long therapy treatment</description>
    <arm_group_label>Therapy with high flow humidification</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Bronchiectasis on HRCT

          -  Optimization of Therapy for at least 15 days before enrollment

          -  Autonomous patients with possibilities of practicing rehabilitations cycles

        Exclusion Criteria:

          -  OSAS (ODI&gt;10/h)

          -  HOME NIV

          -  PH&lt;7,35 - paO2&lt; 60mmHg, paCo2&gt; 55 mmHg

          -  Lung cancer

          -  Contraindication to high-flow nasal cannula (hfnc)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Giuseppe Fiorentino, Doctor</last_name>
    <phone>+393478482564</phone>
    <email>giuseppefiorentino1@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rosa Cauteruccio</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa Cauteruccio, Doctor</last_name>
      <phone>+393392193620</phone>
      <email>rosacauteruccio@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 21, 2019</study_first_submitted>
  <study_first_submitted_qc>October 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2019</study_first_posted>
  <last_update_submitted>October 25, 2019</last_update_submitted>
  <last_update_submitted_qc>October 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Monaldi Hospital</investigator_affiliation>
    <investigator_full_name>Dr. Giuseppe Fiorentino</investigator_full_name>
    <investigator_title>Director Giuseppe Fiorentino</investigator_title>
  </responsible_party>
  <keyword>Bronchiectasis</keyword>
  <keyword>High Flow Therapy</keyword>
  <keyword>Humidifcation</keyword>
  <keyword>Lung Infection</keyword>
  <keyword>Quality of life</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiectasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_info_type>Study Protocol</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

